Mellor AL - Search Results

1

Indoleamine 2,3 dioxygenase, age, and immune activation in people living with HIV.

Baer SL, Colombo RE, Johnson MH, Wakade S, Pacholczyk G, Newman-Whitlow C, Thompson SA, Saag MS, Martin JN, Floris-Moore M, Huang L, Mellor AL. Baer SL, et al. Among authors: mellor al. J Investig Med. 2021 Aug;69(6):1238-1244. doi: 10.1136/jim-2021-001794. Epub 2021 Apr 19. J Investig Med. 2021. PMID: 33875612 Free PMC article.

2

Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy.

Mellor AL, Chandler P, Lee GK, Johnson T, Keskin DB, Lee J, Munn DH. Mellor AL, et al. J Reprod Immunol. 2002 Oct-Nov;57(1-2):143-50. doi: 10.1016/s0165-0378(02)00040-2. J Reprod Immunol. 2002. PMID: 12385839 Review.

3

Indoleamine 2,3 dioxygenase and regulation of T cell immunity.

Mellor A. Mellor A. Biochem Biophys Res Commun. 2005 Dec 9;338(1):20-4. doi: 10.1016/j.bbrc.2005.08.232. Epub 2005 Sep 8. Biochem Biophys Res Commun. 2005. PMID: 16157293 Review.

4

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.

Mellor AL, Baban B, Chandler PR, Manlapat A, Kahler DJ, Munn DH. Mellor AL, et al. J Immunol. 2005 Nov 1;175(9):5601-5. doi: 10.4049/jimmunol.175.9.5601. J Immunol. 2005. PMID: 16237046

5

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

Hou DY, Muller AJ, Sharma MD, DuHadaway J, Banerjee T, Johnson M, Mellor AL, Prendergast GC, Munn DH. Hou DY, et al. Among authors: mellor al. Cancer Res. 2007 Jan 15;67(2):792-801. doi: 10.1158/0008-5472.CAN-06-2925. Cancer Res. 2007. PMID: 17234791

6

Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.

Manlapat AK, Kahler DJ, Chandler PR, Munn DH, Mellor AL. Manlapat AK, et al. Among authors: mellor al. Eur J Immunol. 2007 Apr;37(4):1064-71. doi: 10.1002/eji.200636690. Eur J Immunol. 2007. PMID: 17343295 Free article.

7

Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

Munn DH, Mellor AL. Munn DH, et al. Among authors: mellor al. J Clin Invest. 2007 May;117(5):1147-54. doi: 10.1172/JCI31178. J Clin Invest. 2007. PMID: 17476344 Free PMC article. Review.

8

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, Azuma M, Blazar BR, Mellor AL, Munn DH. Sharma MD, et al. Among authors: mellor al. J Clin Invest. 2007 Sep;117(9):2570-82. doi: 10.1172/JCI31911. J Clin Invest. 2007. PMID: 17710230 Free PMC article.

9

Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

Muller AJ, Sharma MD, Chandler PR, Duhadaway JB, Everhart ME, Johnson BA 3rd, Kahler DJ, Pihkala J, Soler AP, Munn DH, Prendergast GC, Mellor AL. Muller AJ, et al. Among authors: mellor al. Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17073-8. doi: 10.1073/pnas.0806173105. Epub 2008 Oct 24. Proc Natl Acad Sci U S A. 2008. PMID: 18952840 Free PMC article.

10

T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.

Kahler DJ, Mellor AL. Kahler DJ, et al. Among authors: mellor al. Handb Exp Pharmacol. 2009;(188):165-96. doi: 10.1007/978-3-540-71029-5_8. Handb Exp Pharmacol. 2009. PMID: 19031026 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page